Arena Pharmaceuticals reviews lower net lack of $31.3 million in first-quarter 2010 Arena Pharmaceuticals, Inc. today reported monetary results for the 1st quarter finished March 31, 2010 /sildenafil-citrate.html sildalist.org . Arena reported a lower net loss in the first quarter of 2010 of $31.3 million, or $0.33 per share, in comparison to a net reduction in the initial quarter of 2009 of $50.6 million, or $0.68 per share. ‘We believe that lorcaserin represents a significant medical and commercial chance based on the drug candidate’s unique combination of safety, efficacy and tolerability in our pivotal trial program,’ stated Jack Lief, Arena’s President and Chief Executive Officer.
Ariad Health care chosen to be lead marketing agency for Multibionta Probiotic Multivitamin EMD Serono Canada offers chosen Ariad Health care to be its lead marketing agency for Multibionta Probiotic Multivitamin, starting with 2010 commercialization strategies and applications.K. Ariad is operating alongside Rao Barrett & Welsh also, Environics and M2 Universal.